Science

I could smell it before I read it: that warmed-over sanctimony like somebody tried to slow-smoke a stack of legal briefs next to my brisket and called it “public service.” The vibe where your pickup is a sin and your electric bill is somebody’s new revenue stream.

Well tighten the lid on the sauce. The U.S. Supreme Court just grabbed the collar of this climate-lawsuit rodeo.

Supreme Court grants review in Suncor v. Boulder County climate damages lawsuit

On February 23, 2026, the Supreme Court granted the petition in Suncor Energy (U.S.A.) Inc., et al. v. County Commissioners of Boulder County, et al., the Boulder-area lawsuit trying to pin climate-change costs on oil and gas companies.

And the Court didn’t stop at “we’ll take a look.” It also ordered briefing on an extra question: whether the Court even has statutory and Article III jurisdiction to hear the case right now. Translation in F-150 language: before the engine revs, the justices want to confirm they’re even on the right track.

The companies argue these claims shouldn’t be run through a patchwork of state courts trying to regulate a global issue. Boulder and other local governments say they need money for climate-related damages and want the cases to stay in state court. Across these lawsuits, the money demanded is described in the billions.

The trial-lawyer brisket line: follow the smoke to the cash

Here’s the core fight: not just “who pays,” but “who sets the rules.” The climate-litigation complex wants 50 different legal grills running at 50 different temperatures, because inconsistency is leverage. It’s easier to squeeze settlements when the target can’t get a single, clear national rule.

And no, this isn’t me wearing a “Big Oil Fan Club” hat. It’s Big Common Sense. If your plan for climate policy is to let a local judge effectively steer national energy rules through tort law, you’re not governing. You’re cosplay in a robe.

Climate science is real. Weather is not your feelings. But climate litigation isn’t science. It’s persuasion, and sometimes performance art. A jury isn’t peer review. Cross-examination isn’t replication. Courts love clean stories even when the real world is messy, multi-causal, and spread across decades, borders, and billions of decisions by consumers, governments, and industry together.

EPA pulled a giant lever too, and the lawsuits are colliding with regulation

Now add lighter fluid: the Environmental Protection Agency says it finalized a rescission of the 2009 greenhouse gas endangerment finding on February 12, 2026, along with repealing greenhouse gas emissions standards for light-, medium-, and heavy-duty on-highway vehicles and engines. The EPA calls it the largest deregulatory action in U.S. history and claims savings of over $1.3 trillion.

So the regulatory map is shifting while the litigation map is heating up. If the federal government steps back from one regulatory theory, do state and local governments try to fill the vacuum through lawsuits? Or does federal law still slam the door on that state-by-state workaround?

What it means for America

This is bigger than a niche Colorado squabble. It’s a test of whether America makes national policy through elected lawmakers and clear federal rules, or through a thousand lawsuit darts aimed at the biggest balance sheet. You can’t run a superpower on settlement checks and courtroom climate taxes.

Now pass the tongs and let the justices do what they do. If Boulder wants to run national energy policy from a state courtroom, why stop there? Should my local softball umpire start regulating the Federal Reserve too?

The fluorescent light in my skull is doing that thing again. Too much caffeine, too little sleep, and a government move that makes you scan for the nearest fire exit. The public health machine is already rattling. Then somebody decides to swap drivers mid-highway. Not because the engine purrs, but because the people in charge want the noise turned down.

NIH Director Jay Bhattacharya is tapped as acting CDC director after CDC chief Susan Monarez is fired

Over the last few days, the Trump administration stacked two of the country’s biggest health levers in the same hands. NIH Director Jay Bhattacharya is now also the acting director of the CDC. He keeps his NIH job while taking the CDC wheel, at least temporarily.

This comes after CDC Director Susan Monarez was abruptly fired. Reporting says she refused to approve changes to the childhood vaccination schedule without sufficient data, changes sought by HHS Secretary Robert F. Kennedy Jr. The administration says it will nominate someone later. The structure is simple: Bhattacharya in, Monarez out, Kennedy pushing in the background. Read that again, slowly, like you’re under oath.

Translation: this is not efficiency, it is control

Translation: when they tell you one person can run NIH and CDC at the same time, what they mean is the part they want to run is the messaging. The inconvenient part, the slow part, the biostatistics-and-advisory-committees part, gets treated like clutter outside a hearing room.

The NIH is supposed to be the grant engine and scientific switchboard. The CDC is supposed to be the nation’s risk accountant. Lash them together under one acting appointment and it looks like coordination, but it functions like insulation: fewer independent choke points, fewer internal vetoes, fewer scientists raising their hands and asking for data you do not have.

And the Monarez detail matters. A professional boundary, punished: she reportedly wouldn’t sign off on changes without adequate data.

Here is the mechanism: gut the guardrails, then blame the crash on the guardrails

Here is the mechanism: you create instability at the top, swap leadership like a reality show, and call it “reform.” Every shake-up turns civil servants into professional hostages. Their incentive becomes survival, not truth-telling. Meanwhile, political appointees get the ability to steer without leaving a clean paper trail that gets challenged in court.

Agency capture is not always a briefcase of cash. Sometimes it is a calendar invite. Sometimes it is an acting title.

CBS reports Bhattacharya told Congress this month that people should get vaccinated against measles and that he has not seen evidence that vaccines cause autism. Good. Fine. Basic. The floor.

But the real question is whether the institutions around him will be allowed to do their jobs when their conclusions collide with the political project sitting one level above them.

Follow the money: the grift is not just who profits, it is who stops paying

Follow the money: public health moves markets. Vaccine policy moves contracts. Outbreak response moves procurement. Research priorities decide which diseases get cured and which ones get “managed” forever.

When scientific integrity is weakened, the winners are not “skeptics.” The winners are private actors who can sell certainty while the government sells confusion. The losers are patients who need clear guidance, and researchers who need stable institutions that do not treat evidence like a partisan accessory.

The quiet part: they want science to be obedient, not accurate

The quiet part: this is about disciplining institutions that sometimes tell presidents no. You do it with the softest weapon in Washington: uncertainty. Acting titles. Temporary assignments. Perpetual churn. Everybody waiting to see who gets confirmed next, who gets fired next, who gets reassigned next. Meanwhile, the lab lights flicker and the public watches professionals get punished for asking for data.

Accountability is not a tweet, it is a process: Congress should subpoena the firing record and communications around proposed vaccine schedule changes. Inspectors general should audit whether scientific decision-making was pressured or bypassed. Career staff should document everything. Universities and medical associations should testify, not whisper. Voters should treat public health sabotage like the cost shift it is.

Because if evidence can be fired, what exactly is left to protect your kid, your parents, and your neighbors when the next outbreak hits?

I have read enough committee-room prose to recognize the scent of “temporary” power trying to become furniture. The file gets stamped, the database grows, and the public gets a calming memo about how the adults are on it.

This week, the adults are on FISA Section 702.

What Lee and Durbin say the SAFE Act does

On February 23, Senators Mike Lee and Dick Durbin introduced the Security And Freedom Enhancement Act of 2026, nicknamed the SAFE Act. The pitch is straightforward: reauthorize Section 702 for two years, but add guardrails meant to slow surveillance creep.

The bill’s central idea is narrow but consequential. If the government wants to access the contents of Americans’ communications that were swept up under Section 702, it should first get a FISA Title I order or a warrant. Not for targeting foreigners abroad. Not for every initial query. For the moment the state moves from casting the net to reading what it caught.

The Paine test: does this expand liberty or concentrate power?

Section 702 exists because foreign intelligence threats are real, and modern adversaries move faster than Congress schedules hearings. Fine. But the American bargain is supposed to be that “useful” is not a constitutional standard. Judges, due process, and warrants are.

The SAFE Act tries to keep the foreign authority running while building a court-ordered backstop before Americans’ content gets accessed through U.S. person searches. The bill text also describes exceptions for exigent circumstances, consent, and cybersecurity-related searches. Those can be life-saving. They can also become the part everyone drives through unless oversight is sharp.

The Orwell check: when “query” means “search”

Washington loves a euphemism. “Query” sounds like a librarian asking for a call number. “Search” sounds like the state rummaging through your desk. Same action, different lighting.

The SAFE Act at least treats that language problem as a real problem, distinguishing running a query from accessing content. But the public’s concern is still the same: whether the government can look at Americans’ private communications without the traditional Fourth Amendment choreography.

The liberty ledger: who gets protected, who gets exposed?

• Protected: the Fourth Amendment gets a more explicit seat at the table, and the bill targets the “data broker loophole” where agencies buy sensitive personal data, including location history, instead of going to a judge.
• Exposed: the bill is not a full reset. It does not abolish Section 702. It aims for a procedural brake at the most sensitive moment: accessing content tied to Americans.

Guardrails, not slogans

The SAFE Act nods toward transparency and oversight, leaning on auditing and reporting, and it bolsters the role of amici in FISA Court proceedings so judges are not always hearing from one side.

A two-year reauthorization is the right instinct. If a tool is vital, it is vital enough to justify frequent reconsideration. Sunsets are not a bug. They are Congress’s only alarm clock.

Now comes the grown-up part: hearings, sworn testimony, real numbers, real definitions, and a vote in daylight. The question is whether Congress can keep these reforms honest once the lobbying blizzard starts.

I can smell it before I even see it: burnt coffee, printer toner, and panic. That is the grant-industrial complex realizing somebody might crack a window and let daylight hit the process.

Because when Washington starts saying things like “new management structure” and “merit review reform,” the binder-clutchers start fanning themselves like they leaned too close to the brisket smoker.

Feb. 25 National Science Board meeting: management structure + merit review reform

A Sunshine Act notice sets a National Science Board meeting for Wednesday, February 25, 2026, from 11:35 a.m. to 4:20 p.m. Eastern, in Washington, D.C. and by video, with open portions viewable online.

The public agenda includes:

• A briefing and discussion on NSF’s new management structure
• Dedicated time on NSF merit review reform
• Items tied to Science and Engineering Indicators 2026 updates
• Closed-session business later in the day

That is the official, paperwork version. The human version is simpler: the National Science Foundation is a major piggy bank for research, and the Board that oversees it is teeing up a public talk about how NSF is run and how it decides what gets funded.

Merit review is the gate. Who has been holding the keys?

In F-150 logic, merit review is the checkpoint where a panel decides who gets to drive the federal money convoy and who gets sent to the shoulder with a flat tire and a sad violin.

The villain is not the scientist grinding away in a lab at 2 a.m. The villain is the grant-grifter ecosystem between taxpayers and discovery: the professional class that benefits when the system stays complicated enough that only they can navigate it, then calls the toll “compliance.”

Sunshine is a disinfectant. It is also a spotlight for excuses.

Yes, boards have closed sessions. Fine. But the open portion is where the meat is: NSF leadership on management structure, and the Board talking merit review while the public can watch.

And that matters, because the biggest scam is pretending decisions are “neutral” just because they are wrapped in acronyms. Criteria is power. Power is not neutral. It is what the paper-pusher class trades like poker chips.

Who benefits: taxpayers and researchers, or the toll booths?

If NSF changes management and review, somebody wins. In a sane country, it is the taxpayer and the honest researcher with an actual idea, not a 90-page incantation. In the swampy model, the winners are the middlemen, the admin empires, and the process-addicted gatekeepers whose control is procedural.

The National Science Board meets February 25. The agenda says management structure and merit review reform. Good. Let America watch. Let the questions get asked out loud.

The office coffee tastes like burnt pennies, and the printer is spitting out budget spreadsheets like it is angry at me personally. In the hearing rooms and the lobby corridors, researchers are doing what they always do: keeping the freezers cold, the grad students paid, and the clinical trials honest. And now the National Institutes of Health is taking a marker to one of the last clean pieces of public math in the federal grant machine: the payline.

NIH is moving away from published grant paylines

NIH has rolled out a unified funding strategy that, beginning with the January 2026 council round, stops treating traditional paylines as the default way to decide what gets funded. Instead of a clear cutoff tied to peer review scores, NIH says it will weigh a broader mix of factors: peer review information, alignment with NIH and institute priorities, investigator career stage, geographic distribution, and an applicant’s existing NIH funding portfolio. NIH leadership sells this as a way to make award decisions clearer and more consistent across institutes and centers. The policy is described in an NIH Extramural Nexus post and echoed in advisory council materials.

In isolation, the pitch sounds respectable: do not worship a single number, use judgment, read the critiques, fund what matters.

But I have been around enough bureaucracies to know what “more judgment” usually means.

Translation: more discretion means more room for influence

Translation: “We are discontinuing paylines” can land as “We are making it harder for outsiders to predict, audit, and contest our choices.” Paylines were never perfect, and exceptions happened. But they gave applicants and institutions a visible benchmark. It was not justice, but it was at least a receipt.

Now the receipt becomes a paragraph about “priorities,” “portfolio balance,” and “geographic distribution.” Those goals are not automatically bad. But they are squishy. And squishy is where capture lives.

Once “alignment with priorities” becomes central, applicants react like rational actors. They do not just do better science. They write to the priorities. They call the program officer more. They hire the grant consultant. They workshop language through university compliance. The grant starts to look less like peer review and more like a pitch deck.

Here is the mechanism: the score still exists, but the lever moves

Here is the mechanism: peer review still happens, but power shifts toward the internal decision layer where priorities and budgets get translated into winners and losers. NIH says it will consider peer review information “in its entirety” rather than using paylines to build pay plans, while institute directors retain delegated authority to decide what gets funded. Advisory council materials describe institutes and centers discontinuing use of paylines while weighing scores alongside priorities, career stage, and geography.

That is not a small procedural tweak. It is a redistribution of uncertainty. And uncertainty is not evenly distributed.

Follow the money: who wins when the rules get less legible

Follow the money: when the rules start to feel like vibes, the system rewards proximity, not just brilliance. Deep-pocketed universities can float staff, pay bridge funding, and keep people employed while “holistic” decisions churn. Smaller institutions cannot. When predictability shrinks, they do not just lose a project. They lose people.

Meanwhile, every time a public funding system gets harder to navigate, the private sector shows up like a smiling repo man: foundations pick and choose, venture capital cherry-picks, industry money pulls research toward corporate priorities. The public mission gets squeezed.

The quiet part: priorities can become a loyalty test

The quiet part: once “priorities” become the center of gravity, they can be politicized without rewriting a statute. “Unified strategy” sounds like clean whiteboard talk. In practice, priorities are where ideology can hide in plain sight, used to uplift neglected needs or to punish research that makes powerful people uncomfortable.

Maybe NIH can run this with integrity. But if NIH wants trust, it has to earn it with sunlight, not slogans. Congress should demand transparent reporting on award decisions under the new framework. Inspectors general should audit for bias and inconsistency. Watchdogs should FOIA criteria and decision memos. Universities should organize their research workforce to push back against politicized “priorities.” If NIH is going to kill the payline, what exact safeguards keep lobbyists from drawing the new invisible line?

I am staring at a stack of printer paper that smells like stale coffee and betrayal. This is the kind of paperwork that arrives right before someone tells a postdoc their project is “paused” for reasons that have nothing to do with evidence. Outside: neon and sirens. Inside: committee-room air, dry enough to make you forget you are supposed to breathe.

On February 19, 2026, House Democrats sent the White House a letter asking for something that should be automatic in a functioning democracy: receipts. They want transparency on the President’s Council of Advisors on Science and Technology (PCAST). They want the administration to stop treating federal research like a discretionary tip jar. The letter is addressed to OSTP Director Michael Kratsios and to David Sacks, the White House special advisor for AI and crypto and chair of PCAST.

Two days later, on February 21, 2026, the question is not whether the letter is polite. It is. The question is why the United States has to beg for a public record of who is advising the President on science while the same White House sells a glossy “innovation” story.

What lawmakers say is missing

The complaint is basic. PCAST was reestablished in January 2025, but there are no recent public records that clearly document progress or even current membership, and publicly available PCAST materials appear dated. The lawmakers ask for a formal report: plans, updates, membership, initiatives, meeting schedule, achievements. The stuff you publish when government is not being run like a private club.

The letter also points to the stakes: the President’s FY2026 budget proposal seeks to reduce total federal R&D by 22% compared to FY2025 continuing resolution levels, with at least 20% reductions proposed for NASA, NSF, NIH, and DOE, and a proposed 43% cut to NIST. It notes appropriators rejected drastic cuts in a bipartisan spending package, but warns funding still may not be enough to maintain competitiveness.

Translation: transparency means “stop ghosting the public”

Translation: when members of Congress say “provide a formal report,” they mean stop going quiet while you steer the country’s science priorities out of public view.

PCAST is supposed to help set national science and technology priorities. It is not supposed to be a mystery box. And symbolism matters: a council chaired by the White House’s special advisor for AI and crypto is operating with low public visibility, right as AI policy becomes a corporate gold rush. Government-by-omniscient-silence is not a clerical mistake. It is a tactic.

Here is the mechanism: starve the commons, then sell “partnership”

Here is the mechanism: you squeeze public research funding, create uncertainty, then wave “efficiency” and “merit” language like a badge. Universities and labs get pushed to hunt for private money to keep the lights on. The actors who can float the gap are not community colleges or state labs. The gap gets floated by big tech, big pharma, and defense contractors, and research agendas drift toward profitable products, proprietary models, and contracts.

Follow the money: subsidy now, control forever

Follow the money: federally funded science underpins private sector innovation. That is why the fight over federal R&D is vicious. The public is the seed corn. Corporations want the silo and the key. And when Congress has to write a letter to get basic transparency about the President’s science council, you can smell the incentive structure through the paper.

The quiet part

The quiet part: they want science that serves power, not people. Scientific integrity is not just clean datasets. It is visible governance. Publish membership. Publish meetings. Publish the agenda. Then bring it into oversight hearings under bright lights, because a council that leaves no fingerprints is a council that cannot be cross-examined.

My mic-drop is boring on purpose: subpoena the documents, audit the process, empower inspectors general, and make appropriations conditional on real transparency. Then let the research workforce organize like their livelihoods matter, because they do.

I keep thinking about the old library card catalog: wooden drawers, brass labels, and a civic assumption that access comes with rules. If somebody abused the system, the answer was not “build a faster catalog.” The answer was enforcement of the rules.

Washington, as usual, prefers the opposite order: build first, argue about limits later, ideally behind a euphemism and a locked committee door.

What DHS is trying to build

On February 20, WIRED reported that the Department of Homeland Security is moving toward consolidating facial recognition and other biometric tools into a single “matching engine,” based on records it reviewed. The idea: one system that can compare faces, fingerprints, iris scans, and more across DHS components, serving routine identity checks and investigative searches, and connecting agencies that do not currently share data easily.

Biometric Update also described a DHS Request for Information aimed at industry input for an enterprise biometric matching capability spanning major DHS components, including multimodal matching, adjustable thresholds, and extensive logging and auditability.

This is not science fiction. It is procurement, which is how policy sneaks into the building wearing a hard hat and carrying an invoice.

Why this is a power upgrade, not just a tech upgrade

WIRED’s reporting describes a department-wide system touching components such as CBP, ICE, TSA, USCIS, the Secret Service, and DHS headquarters, supporting missions like watch-listing and detention or removal operations. Centralization lowers friction, and friction is sometimes the last guardrail a free society has left.

WIRED also highlights a distinction that matters: verification (one-to-one, “are you who you claim?”) versus identification (one-to-many, “who is this person in the database?”). The second category is where false positives and mission creep tend to multiply.

Then there is the footnote that should not be a footnote: WIRED notes a placeholder indicating DHS wants to incorporate voiceprint analysis, without detailed plans for collection, storage, or search.

The Orwell check: “interoperability” as a permission slip

My Orwell check is simple: listen to the vocabulary. “Interoperability,” “modernization,” “enterprise solution.” Those are conference-badge words. In practice, they often mean broader access and easier searching.

And DHS itself has described what guardrails look like when they are written down. In a January 2025 archived post summarizing a 2024 update, DHS described Directive 026-11 as requiring bias and disparate impact testing, opt-out for U.S. citizens for non-law enforcement uses, a rule that facial recognition cannot be the sole basis for law or civil enforcement action, and oversight reviews by offices including the DHS Privacy Office and the Office for Civil Rights and Civil Liberties.

WIRED, however, describes DHS pursuing this consolidation after dismantling centralized privacy reviews and key limits on facial recognition. If that is accurate, the story is not only a bigger engine. It is fewer brakes.

The liberty ledger and the Paine test

The liberty ledger: DHS gains speed and a single window into multiple biometric workflows. The public takes the risk: travelers, immigrants, and anyone easiest to scan and hardest to defend. NIST’s face recognition testing has long underscored that performance and error rates vary with image quality, use case, and demographics. Adjustable thresholds are not just a technical knob. They are a constitutional decision.

The Paine test: does this expand liberty, or concentrate power? A department-wide biometric search box concentrates power by making broader searching cheaper and easier.

Guardrails to bolt on before “procurement” becomes “policy”

• Publish the governing rules: thresholds, authorized uses, retention limits, and redress mechanisms.
• Separate verification from investigative identification, with distinct legal standards and audits.
• Independent audits with public reporting, not just internal compliance memos.
• Meaningful due process: if you get flagged, you should be able to learn it, challenge it, and correct it.
• Explain, in plain language, what remains of the earlier opt-outs and oversight DHS once described, and what was removed.

Sunlight is not a nuisance. It is the operating system of self-government. So here is the question: if DHS is building a single biometric search box for multiple agencies, what exact, published rule stops it from becoming a national suspicion machine?

I smelled it before I finished the first paragraph. That familiar federal cocktail: a budget axe swinging in one hand, and “innovation” cologne sprayed with the other. The kind of situation where Washington unplugs people and then acts shocked when a shiny tool shows up pretending to be a miracle.

NIH: more AI use cases, fewer employees

According to federal inventory reporting and agency talk around NIH’s AI adoption, the trend line is clear: staffing shrinks while AI pilots grow. NIH’s headcount fell to roughly 17,000 employees in early 2026, down by more than 4,000 from just over a year earlier. At the same time, NIH’s reported AI use cases climbed to 124 in fiscal 2025, up from 82 in 2024, based on the HHS AI use-case inventory published under federal requirements.

Brick’s F-150 math: tools are fine, replacing the crew is not

I am not here to boo a calculator. I like tools. AI can absolutely be a tool. But when an agency that deals in life-and-death science loses thousands of workers and then leans harder on pilots, you do not get “efficiency.” You get shortcuts, burnout, and dashboards screaming “ALL GOOD” while the oil light flashes.

NIH officials and speakers have described AI work spanning:

• Administrative tasks (like analyzing grant portfolios)
• Research support and lab work
• Clinical assistance

A lot of it is still pilot or pre-deployment, meaning it is revving in the parking lot, not hauling a trailer across the country. And NIH folks have been blunt that scaling is the hard part, where messy data, foggy rules, and real accountability come due.

The vendor swamp and the “$1 deal” worry

Now for the villain: procurement gravity. NIH, like other agencies, has leaned on bundled buying efforts through GSA, including OneGov, launched in April 2025 to treat the federal government like one customer. Sounds clean in theory. In practice, it can become the classic trap: cheap up front, expensive forever.

One NIH technology leader raised concern about the “drug dealer model” of $1 deals that later sunset. Translation: free samples today, renewal shock tomorrow, after your workflows and training are already chained to the platform.

Small language models, big leverage

NIH speakers have discussed building domain-specific small language models trained on large NIH datasets (including Alzheimer’s data) so researchers can ask questions within a tight, controlled domain. That direction is promising. Small and auditable beats giant black-box oracle.

NIH is also running a generative AI community of practice with roughly 2,000 people, pushing training and careful use (including human-in-the-loop and data protection). Good guardrail talk. But guardrails take staff, time, and spine, especially across NIH’s 27 institutes and centers.

If you drain the workforce and replace it with pilots, you are not modernizing. You are outsourcing responsibility and praying the discount never ends.

The newsroom coffee tastes like burned budget hearings. My phone lights up with the kind of bad news that never comes with sirens because the damage is bureaucratic, quiet, and built for plausible deniability. Somewhere in a federal office, someone decided the threat is not the next outbreak. The threat is the vocabulary we use to warn you it is coming.

NIAID staff told to delete “biodefense” and “pandemic preparedness” from the website

This week, Nature reporting described a directive inside the National Institute of Allergy and Infectious Diseases (NIAID) to scrub the terms “biodefense” and “pandemic preparedness” from web pages, citing emails it says it obtained. Scientific American amplified that reporting. CIDRAP summarized it plainly: delete the words, deprioritize the work, and call it a reorganization.

Translation: a website scrub in Washington is not a typo fix. It is a power signal.

Translation: censorship with a lab coat

Translation: “scrub the words” means “scrub the mission.” It redraws the public-facing map of what NIAID does so later budget moves look like routine housekeeping. First you erase a phrase. Then you erase a program. Then you erase a grant line. Then you erase a career.

Yes, they will tell you it is about “focus,” “impact,” and “gold standard science.” CIDRAP notes NIH Director Jay Bhattacharya and coauthors have framed the shift as prioritizing diseases Americans “currently face,” alongside immunology, allergy, and autoimmune work. Those needs are real. That is not the point. You do not build a fire department by banning the word “fire” from the station door.

Here is the mechanism: erase the label, then starve the line item

Here is the mechanism: research priorities are set not only in labs, but in memos, websites, and budget narratives that define what counts as “core” versus “legacy.” If you want to downgrade a mission without owning the consequences, you make it harder to point to.

Once “pandemic preparedness” disappears from official language, future cuts get easier. Cancellations become “not aligned.” Whistleblowers become “confused.” The paper trail becomes fog.

CIDRAP also points to context: about a third of NIAID’s roughly $6.6 billion budget supports studies on pathogens of concern and protective measures against emerging infectious disease threats, alongside a broader NIH workforce reduction since January 2025 and the earlier idling of the White House Office of Pandemic Preparedness and Response Policy in June 2025. That is not an editing choice. That is a pattern.

Follow the money: costs migrate, chaos pays

Follow the money: when public health readiness shrinks, the bill does not vanish. It lands on nurses, teachers, warehouse workers, and families who cannot take unpaid leave. It lands on state budgets and hospital systems forced to improvise.

And the winners? Private vendors selling emergency fixes at premium prices. Political operators running on chaos they helped engineer. Industries that hate regulation and love an enforcement state too distracted to enforce anything.

The quiet part: make preparedness sound like a conspiracy genre

The quiet part is narrative control. If you can make “pandemic preparedness” sound like a discredited buzzword, you can treat the next warning like partisan noise and pre-discredit the people who will later say, “we told you.” Change the vocabulary and you make accountability questions harder to ask.

Congress should subpoena the emails. Inspectors general should audit the decision chain and any downstream grant reprioritizations. Scientific institutions should stop whispering and start naming the sabotage in plain English. Because if they are proud of this, why does it look like a back-alley rewrite instead of a public hearing?

Under the library fluorescents, everything looks like evidence, including our favorite national bedtime story: we can kick the legs out from under the future and still demand it arrive on schedule.

The latest warnings about a scientific brain drain are not mysterious. If you freeze or terminate research money midstream, the people trained to measure reality will measure the risk and relocate. They rarely slam doors. They just pack their notebooks.

Trump-era science cuts, grant churn, and a recruitment market overseas

Here is the plain-language version: federal science has been whipsawed, and early-career researchers are catching the worst of it. Grants get frozen or terminated. Hiring slows. Programs narrow by politics instead of peer review. Then officials look around like morale vanished on its own.

Nature quantified the chaos: 5,844 NIH grants and 1,996 NSF grants were cancelled or suspended, with more than 7,800 grants affected over the course of 2025. Courts have ordered thousands reinstated, but Nature notes it is unclear how many scientists have actually received restored funds. It also reports roughly 2,600 grants had not been reinstated or unfrozen, totaling $1.4 billion in unspent funding.

That is not an abstract culture-war bar chart. That is a lab shutting down. That is a clinical team being told the money is here, then not here, then maybe here again after a judge intervenes.

Meanwhile, Europe is not treating this like a spectator sport. Inside Higher Ed reported European governments and universities building recruitment efforts aimed at US-based researchers, explicitly selling stability and, in some cases, refuge from political pressure. If you are holding a mortgage-sized grant that just got turned into confetti, “stability” is not a slogan. It is a plan.

What this breaks (and why taxpayers should care)

The US government is not just a checkbook for science. It is the referee. When politics starts grading the papers, incentives rot. Not because scientists are saints, but because they are human and respond to the environment you build.

And the disrupted work is not a boutique hobby. The CDC estimates more than 2.8 million antimicrobial-resistant infections a year in the US and more than 35,000 deaths. When you add C. diff, the CDC puts the total above 3 million infections and 48,000 deaths.

The Paine test and the Orwell check

• The Paine test: when grantmaking becomes a loyalty test, power concentrates in opaque executive discretion, not transparent rules you can challenge.
• The Orwell check: “efficiency” and “accountability” are fine words until they show up without clear metrics, published criteria, or a real appeals process.

We can debate priorities and fraud controls. We should. But yanking research support around like a steering wheel in an ice storm is not oversight. It is sabotage with paperwork.